Hexachlorobutadiene (CASRN 87-68-3)
view QuickView
0058
Hexachlorobutadiene; CASRN 87-68-3
Health assessment information on a chemical substance is included in IRIS only after a comprehensive review of chronic toxicity data by U.S. EPA health scientists from several Program Offices and the Office of Research and Development. The summaries presented in Sections I and II represent a consensus reached in the review process. Background information and explanations of the methods used to derive the values given in IRIS are provided in the Background Documents.
STATUS OF DATA FOR Hexachlorobutadiene
File First On-Line 01/31/1987
Category (section) |
Status |
Last Revised |
---|---|---|
Oral RfD Assessment (I.A.) | withdrawn | 05/01/1993 |
Inhalation RfC Assessment (I.B.) | no data | |
Carcinogenicity Assessment (II.) | on-line | 04/01/1991 |
_I. Chronic Health Hazard Assessments for Noncarcinogenic Effects
_I.A. Reference Dose for Chronic Oral Exposure (RfD)
Substance Name — Hexachlorobutadiene
CASRN — 87-68-3
The Oral RfD for hexachlorobutadiene has been withdrawn on 05/01/1993 as a result of further review. A new RfD summary is in preparation by the RfD/RfC Work Group.
Agency Work Group Review — 12/18/1985, 04/01/1993
EPA Contacts:
Please contact the IRIS Hotline for all questions concerning this assessment or IRIS, in general, at (202)566-1676 (phone), (202)566-1749 (FAX) or hotline.iris@epa.gov (internet address).
_I.B. Reference Concentration for Chronic Inhalation Exposure (RfC)
Substance Name — Hexachlorobutadiene
CASRN — 87-68-3
Not available at this time.
_II. Carcinogenicity Assessment for Lifetime Exposure
Substance Name — Hexachlorobutadiene
CASRN — 87-68-3
Last Revised — 04/01/1991
Section II provides information on three aspects of the carcinogenic assessment for the substance in question; the weight-of-evidence judgment of the likelihood that the substance is a human carcinogen, and quantitative estimates of risk from oral exposure and from inhalation exposure. The quantitative risk estimates are presented in three ways. The slope factor is the result of application of a low-dose extrapolation procedure and is presented as the risk per (mg/kg)/day. The unit risk is the quantitative estimate in terms of either risk per ug/L drinking water or risk per ug/cu.m air breathed. The third form in which risk is presented is a drinking water or air concentration providing cancer risks of 1 in 10,000, 1 in 100,000 or 1 in 1,000,000. The rationale and methods used to develop the carcinogenicity information in IRIS are described in The Risk Assessment Guidelines of 1986 (EPA/600/8-87/045) and in the IRIS Background Document. IRIS summaries developed since the publication of EPA's more recent Proposed Guidelines for Carcinogen Risk Assessment also utilize those Guidelines where indicated (Federal Register 61(79):17960-18011, April 23, 1996). Users are referred to Section I of this IRIS file for information on long-term toxic effects other than carcinogenicity.
_II.A. Evidence for Human Carcinogenicity
__II.A.1. Weight-of-Evidence Characterization
Classification — C; possible human carcinogen
Basis — Observation of renal neoplasms in male and female rats in one study
__II.A.2. Human Carcinogenicity Data
None.
__II.A.3. Animal Carcinogenicity Data
Groups of 39 or 40 Sprague-Dawley rats/sex/dose were maintained on diets formulated to deliver 0.2, 2 or 20 mg hexachlorobutadiene/kg bw/day. High- dose group males experienced significant increases in mortality. At the end of the 22- or 24-month study period, renal tubular adenomas and carcinomas had developed in 18% of high-dose females. There was no significant increase in incidence of neoplasms at other sites (Kociba et al., 1977).
Hexachlorobutadiene did not induce pulmonary adenomas in strain A mice treated via i.p. injection (Theiss, 1977).
__II.A.4. Supporting Data for Carcinogenicity
Hexachlorobutadiene is not mutagenic for Salmonella typhimurium with or without the addition of rat liver homogenates (Taylor, 1978).
_II.B. Quantitative Estimate of Carcinogenic Risk from Oral Exposure
__II.B.1. Summary of Risk Estimates
Oral Slope Factor — 7.8E-2 per (mg/kg)/day
Drinking Water Unit Risk — 2.2E-6 per (ug/L)
Extrapolation Method — Linearized multistage procedure, extra risk
Drinking Water Concentrations at Specified Risk Levels:
Risk Level |
Concentration |
---|---|
E-4 (1 in 10,000) |
5E+1 ug/L |
E-5 (1 in 100,000) |
5E+0 ug/L |
E-6 (1 in 1,000,000) |
5E-1 ug/L |
__II.B.2. Dose-Response Data (Carcinogenicity, Oral Exposure)
Tumor Type — renal tubular adenomas and adenocarcinomas
Test Animals — rat, Sprague-Dawley, male
Route — diet
Reference — Kociba et al., 1977
Administered Dose (mg/kg)/day |
Human Equivalent Dose (mg/kg)/day |
Tumor Incidence |
---|---|---|
0 |
0 |
1/90 |
0.2 |
0.04 |
0/40 |
2.0 |
0.4 |
0/40 |
20.0 |
4.0 |
9/39 |
__II.B.3. Additional Comments (Carcinogenicity, Oral Exposure)
Test material was 99% pure. Concentrations in diet were adjusted to deliver the above dosages. To obtain equivalent human doses, a rat lifetime of 770 days and a weight of 0.610 kg were assumed.
The unit risk should not be used if the water concentration exceeds 5E+3 ug/L, since above this concentration the unit risk may not be appropriate.
__II.B.4. Discussion of Confidence (Carcinogenicity, Oral Exposure)
There were sufficient numbers of animals tested and there was a significant increase in tumor incidence by comparison to concurrent controls.
_II.C. Quantitative Estimate of Carcinogenic Risk from Inhalation Exposure
__II.C.1. Summary of Risk Estimates
Inhalation Unit Risk — 2.2E-5 per (ug/cu.m)
Extrapolation Method — Linearized multistage procedure, extra risk
Air Concentrations at Specified Risk Levels:
Risk Level |
Concentration |
---|---|
E-4 (1 in 10,000) | 5E+0ug/cu.m |
E-5 (1 in 100,000) | 5E-1 ug/cu.m |
E-6 (1 in 1,000,000) | 5E-2 ug/cu.m |
__II.C.2. Dose-Response Data for Carcinogenicity, Inhalation Exposure
The inhalation risk estimates were calculated from the oral exposure data in Section II.B.2.
__II.C.3. Additional Comments (Carcinogenicity, Inhalation Exposure)
The unit risk should not be used if the air concentration exceeds 5E+2 ug/cu.m, since above this concentration the unit risk may not be appropriate.
__II.C.4. Discussion of Confidence (Carcinogenicity, Inhalation Exposure)
See II.B.4.
_II.D. EPA Documentation, Review, and Contacts (Carcinogenicity Assessment)
__II.D.1. EPA Documentation
Source Document — U.S. EPA, 1980
The 1980 Ambient Water Quality Criteria Document for Hexachlorobutadiene received Agency and peer review.
__II.D.2. EPA Review (Carcinogenicity Assessment)
Agency Work Group Review — 11/12/1986
Verification Date — 11/12/1986
__II.D.3. EPA Contacts (Carcinogenicity Assessment)
Please contact the IRIS Hotline for all questions concerning this assessment or IRIS, in general, at (202)566-1676 (phone), (202)566-1749 (FAX) or hotline.iris@epa.gov (internet address).
_III.
[reserved]
_IV. [reserved]
_V. [reserved]
_VI. Bibliography
Substance Name — Hexachlorobutadiene
CASRN — 87-68-3
Last Revised — 05/01/1993
_VI.A. Oral RfD References
Not available at this time
_VI.B. Inhalation RfC References
None
_VI.C. Carcinogenicity Assessment References
Kociba, R.J., D.G. Keyes, G.C. Jersey, et al. 1977. Results of a two-year chronic toxicity study with hexachlorobutadiene in rats. Am. Ind. Hyg. Assoc. J. 38: 589-602.
Taylor, G. 1978. Personal communication. National Institute of Occupational Safety and Health, Cincinnati, OH. (Cited in U.S. EPA, 1980)
Thiess, J.C., G.D. Stoner, M.B. Shimkin and E.K. Weisburger. 1977. Test for carcinogenicity of organic contaminants of United States drinking waters by pulmonary tumor response in strain A mice. Cancer Res. 37: 2717-2720.
U.S. EPA. 1980. Ambient Water Quality Criteria Document for Hexachloro- butadiene. Prepared by the Office of Health and Environmental Assessment, Environmental Criteria and Assessment Office, Cincinnati, OH for the Office of Water Regulations and Standards, Washington, DC. EPA 440/5-80-053. NTIS PB 81-117640.
_VII. Revision History
Substance Name — Hexachlorobutadiene
CASRN — 87-68-3
Date |
Section |
Description |
---|---|---|
03/31/1987 | II. | Carcinogenicity Section added |
03/01/1988 | II.B.4. | Confidence statement revised |
03/01/1988 | II.C.4. | Confidence statement revised |
06/30/1988 | I.A.6. | Documentation corrected |
06/01/1989 | II.D.3. | Secondary contact changed |
12/01/1989 | VI. | Bibliography on-line |
08/01/1990 | III.A. | Health Advisory on-line |
08/01/1990 | IV.F.1. | EPA contact changed |
08/01/1990 | VI.D. | Health Advisory references added |
01/01/1991 | II. | Text edited |
01/01/1991 | II.C.1. | Inhalation slope factor removed (global change) |
04/01/1991 | I.A. | Text edited |
04/01/1991 | I.A.7. | Secondary contact changed |
04/01/1991 | II.A.3. | 2nd paragraph - text revised |
01/01/1992 | IV. | Regulatory actions updated |
05/01/1993 | I.A. | Withdrawn; new Oral RfD verified (in preparation) |
05/01/1993 | VI.A. | Oral RfD references withdrawn |
08/01/1995 | I.A., VI.A. | EPA's RfD/RfC and CRAVE workgroups were discontinued in May, 1995. Chemical substance reviews that were not completed by September 1995 were taken out of IRIS review. The IRIS Pilot Program replaced the workgroup functions beginning in September, 1995. |
09/01/1996 | III.A.5. | DWEL withdrawn |
04/01/1997 | III., IV., V. | Drinking Water Health Advisories, EPA Regulatory Actions, and Supplementary Data were removed from IRIS on or before April 1997. IRIS users were directed to the appropriate EPA Program Offices for this information. |
02/22/2001 | I., II. | This chemical is being reassessed under the IRIS Program. |
_VIII. Synonyms
Substance Name — Hexachlorobutadiene
CASRN — 87-68-3
Last Revised — 01/31/1987
- 87-68-3
- 1,3-Butadiene, Hexachloro-
- DOLEN-PUR
- GP-40-66:120
- HCBD
- Hexachlor-1,3-Butadien
- HeXachlorbutadiene
- Hexachlorobutadiene
- 1,1,2,3,4,4-Hexachloro-1,3-Butadiene
- 1,3- Hexachlorobutadiene
- Perchlorobutadiene
- RCRA Waste Number U128
- UN 2279